COMP <GO>
BBOT vs SIGA // RSI-14 & 200D SMA MOMENTUM
BridgeBio Oncology Therapeutics Inc. (NASDAQ) VS. SIGA Technologies Inc. (NASDAQ) • 15-METRIC TALLY: BBOT 0
— SIGA 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: SIGA
LAST: $2.31 (-11.83%) • MKT CAP: $210.1M
rsi-technicals
24.1
LAST: $2.95 (-2.96%) • MKT CAP: $218.4M
rsi-technicals
43.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BBOT VS. SIGA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BBOT | SIGA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 68.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 42.70% | -77.70 | SIGA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 4.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 19.03% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 25.10% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 24.60% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -31.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 8.22 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 6/9 | -4.00 | SIGA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 24.1 | 43.5 | -19.40 | SIGA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 9.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $210.1M | $218.4M | -$8.4M | SIGA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BBOT REV | SIGA REV | BBOT GROSS % | SIGA GROSS % | BBOT FCF | SIGA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $408.3M | $94.6M | — | 68.6% | -$114.5M | $43.5M |
| FY 2024 | $226.4M | $138.7M | — | 77.4% | -$55.1M | $48.8M |
| FY 2023 | $116.7K | $139.9M | — | — | — | $94.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BBOT // BETA —
SIGA // BETA —